Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02898506
What this trial is testing

Incretin-based Therapy in Late Preclinical Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
University of Oulu 13
Not applicableStudy completedNCT07297238
What this trial is testing

Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.

Who this might be right for
Short Bowel Syndrome (SBS)Intestinal Failure
Jinling Hospital, China 20
Early research (Phase 1)Study completedNCT01456572
What this trial is testing

Gastric and Intestinal Satiation in Obese and Normal Weight Healthy People

Who this might be right for
Endocrine System Diseases
University Hospital, Basel, Switzerland 65
Not applicableActive Not RecruitingNCT05944432
What this trial is testing

CGM Use in Adults With Type 2 Diabetes on Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Abbott Diabetes Care 469
Not applicableUnknownNCT02236299
What this trial is testing

Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting

Who this might be right for
Right Coronary Artery Percutaneous Coronary InterventionRight Ventricular Diastolic Dysfunction
Papworth Hospital NHS Foundation Trust 30
Not applicableStudy completedNCT01599338
What this trial is testing

Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes MellitusOverweight
Centre Hospitalier Universitaire Dijon 30
Not applicableStudy completedNCT01677104
What this trial is testing

The Microvascular Function of GLP-1 and Its Analogues

Who this might be right for
Type 2 DiabetesObesity
Katarina Kos 63
Very early researchStudy completedNCT02287285
What this trial is testing

Determinants of Diabetes Remission After Gastric Bypass Surgery

Who this might be right for
Type 2 Diabetes Mellitus
Blandine Laferrere 25
Not applicableStudy completedNCT01957098
What this trial is testing

The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in Man

Who this might be right for
Insulin Resistance
University of Copenhagen 14
Not applicableNot Yet RecruitingNCT07711548
What this trial is testing

Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?

Who this might be right for
Obesity & OverweightWeight Loss Maintenance
Knut Mai 292
Testing effectiveness (Phase 2)Study completedNCT03232112
What this trial is testing

Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?

Who this might be right for
Alcohol Dependence, in RemissionAddiction, Alcohol
Anders Fink-Jensen, MD, DMSci 152
Not applicableStudy completedNCT03018444
What this trial is testing

The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion

Who this might be right for
Diabetes Mellitus, Type 2Hydroxymethylglutaryl-CoA Reductase Inhibitors
University Hospital, Gentofte, Copenhagen 15
Not applicableUnknownNCT02673931
What this trial is testing

GLP-1 and Hyperoxia for Organ Protection in Heart Surgery

Who this might be right for
Coronary DiseaseShock, CardiogenicRenal Failure+3 more
Rigshospitalet, Denmark 1,400
Very early researchEnrolling By InvitationNCT07092605
What this trial is testing

Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures

Who this might be right for
LongevityQuality of LifeMood+5 more
AgelessRx 150
Post-approval studies (Phase 4)Study completedNCT01903070
What this trial is testing

Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment

Who this might be right for
Diabetes Mellitus
Profil Institut für Stoffwechselforschung GmbH 99
Not applicableStudy completedNCT07703865
What this trial is testing

Effects of Monday-Thursday Sunnah Fasting on Short-Chain Fatty Acids, GLP-1, Satiety, and Nutritional Status in Obese Males

Who this might be right for
Obesity & OverweightGut -Microbiota
University of Muhammadiyah Jakarta 74
Post-approval studies (Phase 4)Study completedNCT02537834
What this trial is testing

Tofogliflozin GLP-1 Analogue Combination Trial

Who this might be right for
Type 2 Diabetes Mellitus
Kowa Company, Ltd. 65
Not applicableNot Yet RecruitingNCT07638111
What this trial is testing

SENSILINS: Impact of Cephalic Phase Insulin Release Induced by an Environmental Food Odor Stimulus on Glucose Homeostasis According to Insulin Sensitivity Level

Who this might be right for
Obesity & OverweightInsulin Resistance Syndrome
Hospices Civils de Lyon 20
Not applicableNot Yet RecruitingNCT06546384
What this trial is testing

GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease

Who this might be right for
AdiposityFatty LiverAlcohol Use Disorder
Insel Gruppe AG, University Hospital Bern 64
Post-approval studies (Phase 4)WithdrawnNCT01818648
What this trial is testing

Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome

Who this might be right for
Short Bowel Syndrome
Mayo Clinic
Next Page